Share
Market Research Report

BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Service TypeDrug substance/Active Pharmaceutical Ingredient (API) Manufacturing · Drug product/Formulation and Fill-Finish (FDF) · Analytical and Quality Control services · Process development and scale-up/Technology transfer · and Packaging · labeling and ancillary services
  • By Biologic TypeMonoclonal antibodies (mAbs) · Recombinant proteins and enzymes · Vaccines · Cell and gene therapies · Antibody-drug conjugates (ADCs) · and Others (growth factors, cytokines, fusion proteins)
  • By Production SystemMammalian systems (CHO, NS0, HEK) · Microbial systems (E. coli, yeast) · and Alternative/Emerging systems (insect cells, plant, cell-free)
  • By ScalePreclinical/clinical scale manufacturing and Commercial scale manufacturing
  • By Company SizeSmall to Mid-sized Contract Manufacturers and Large Contract Manufacturing Organizations (CMOs/CDMOs)
  • By Therapeutic AreaOncology/Hematology · Immunology and Autoimmune Disorders · Infectious Diseases and Vaccinology · Cardiovascular and Renal Disorders · Neurology and Central Nervous System (CNS) Disorders · Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid) · Respiratory Disorders · and Others (Dermatology, Rare and Orphan Diseases)
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In17 Mar 2026
  • Report CodeCMI8662
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Biologics Contract Manufacturing Market, By Service Type
      • Global Biologics Contract Manufacturing Market, By Biologic Type
      • Global Biologics Contract Manufacturing Market, By Production System
      • Global Biologics Contract Manufacturing Market, By Scale
      • Global Biologics Contract Manufacturing Market, By Company Size
      • Global Biologics Contract Manufacturing Market, By Therapeutic Area
      • Global Biologics Contract Manufacturing Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Biologics Contract Manufacturing Market, By Service Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Drug substance/Active Pharmaceutical Ingredient (API) Manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Drug product/Formulation and Fill-Finish (FDF)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Analytical and Quality Control services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Process development and scale-up/Technology transfer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Packaging, labeling and ancillary services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Biologics Contract Manufacturing Market, By Biologic Type, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Monoclonal antibodies (mAbs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Recombinant proteins and enzymes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cell and gene therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Antibody-drug conjugates (ADCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (growth factors, cytokines, fusion proteins)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Biologics Contract Manufacturing Market, By Production System, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Mammalian systems (CHO, NS0, HEK)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Microbial systems (E. coli, yeast)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Alternative/Emerging systems (insect cells, plant, cell-free)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Biologics Contract Manufacturing Market, By Scale, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Preclinical/clinical scale manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Commercial scale manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Biologics Contract Manufacturing Market, By Company Size, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Small to Mid-sized Contract Manufacturers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Large Contract Manufacturing Organizations (CMOs/CDMOs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Biologics Contract Manufacturing Market, By Therapeutic Area, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oncology/Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Immunology and Autoimmune Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Infectious Diseases and Vaccinology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cardiovascular and Renal Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Neurology and Central Nervous System (CNS) Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Respiratory Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Others (Dermatology, Rare and Orphan Diseases)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Biologics Contract Manufacturing Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Biologic Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Production System, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Scale, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Company Size, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape

    • Lonza
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Thermo Fisher Scientific
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Catalent
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Samsung Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WuXi Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim BioXcellence
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fujifilm Diosynth Biotechnologies
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AGC Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Recipharm
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Siegfried
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Rentschler Biopharma
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abzena
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Charles River Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • IDT Biologika
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Avid Bioservices
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology

    • References
    • Research Methodology
    • About Us

*Browse 32 market data tables and 28 figures on 'Biologics Contract Manufacturing Market' - Global forecast to 2033